ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kansas » Internal Medicine

Top Internal Medicine Prescribers in Kansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHARLES DAVIS MD

Internal Medicine

49,481

$2.64M

861
734 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $58

DONNA SWEET MD

Internal Medicine

31,713

$7.15M

1839
1217 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 13%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 24%

$225
Average prescription price

Avg: $58

AMMAR KHALIFA MD

Internal Medicine

30,391

$1.52M

1014
895 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $58

MARK YACKLEY M.D.

Internal Medicine

27,980

$1.35M

894
733 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $58

BRUCE MCMULLEN MD

Internal Medicine

27,701

$1.46M

631
545 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $58

PATRICK WOLF MD

Internal Medicine

24,806

$1.05M

662
629 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $58

AHMED MADI MD

Internal Medicine

22,659

$1.38M

482
311 are 65+

26%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $58

TIMOTHY CRATER MD

Internal Medicine

21,849

$1.12M

737
616 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $58

ERIC HUERTER M.D.

Internal Medicine

20,499

$1.06M

674
521 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $58

VINAYA KODURI MD

Internal Medicine

20,470

$1.16M

576
355 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $58

AMY SEEBER M.D.

Internal Medicine

20,076

$930K

576
401 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $58

PANDURANG CHILLAL M.D.

Internal Medicine

18,462

$886K

497
385 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

42%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $58

WILLIAM SAVAGE MD

Internal Medicine

18,313

$682K

576
506 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $58

JAMES HIGNIGHT MD

Internal Medicine

17,983

$885K

703
592 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $58

ALAN PRIBIL M.D.

Internal Medicine

17,978

$886K

519
480 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $58

CHRISTOPHER GEHA M.D.

Internal Medicine

17,786

$893K

653
577 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $58

CRAIG CONCANNON M.D.

Internal Medicine

17,709

$775K

524
473 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $58

PRATIP PATEL MD

Internal Medicine

17,586

$933K

552
412 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $58

R. BLOOM M.D.

Internal Medicine

17,544

$985K

455
401 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 13%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $58

JAMES RUHLMANN MD

Internal Medicine

16,778

$839K

771
669 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $58

RICHARD SHOFFNER MD

Internal Medicine

16,180

$879K

811
666 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $58

TAKESHI SETO M.D.

Internal Medicine

16,087

$946K

515
397 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $58

WADE TURNER MD

Internal Medicine

15,751

$853K

505
418 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $58

RICHARD WHITLOW M.D.

Internal Medicine

15,704

$898K

503
393 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $58

MICHAEL HARWOOD MD

Internal Medicine

15,568

$814K

477
385 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank